
Author & Editor: Adam Tomlinson
Clinically Reviewed by: Charee Marquez, LMFT
Clinical Contributor: Karynne Witkin, M.A. I/O Psychology
Cannabinoid Hyperemesis Syndrome: Symptoms, Causes, and Treatment
Cannabis Hyperemesis Syndrome (CHS) is a rare condition that affects regular marijuana smokers, particularly those with chronic cannabinoid use. Characterized by persistent nausea, severe vomiting, and stomach pain, CHS often leads patients to seek relief through compulsive bathing or hot baths, a hallmark symptom of the syndrome. Despite its association with the cannabis plant, CHS is frequently misdiagnosed as cyclic vomiting syndrome or other gastrointestinal issues. The condition poses serious health complications, including emergency department visits, dehydration, and in severe cases, kidney failure or brain swelling. Quitting cannabis is the only definitive treatment, yet many marijuana users struggle with cessation. Medical literature, including the Rome IV criteria, outlines diagnostic criteria for CHS, but it remains a challenging condition for both healthcare providers and patients.
What is Cannabinoid Hyperemesis Syndrome?
Cannabinoid Hyperemesis Syndrome (CHS) is a condition linked to long-term cannabis use. It causes severe nausea, vomiting, and abdominal pain. People with CHS may find relief from these symptoms by taking hot showers or baths, which can temporarily relieve CHS symptoms. The condition occurs in some individuals who use cannabis regularly, especially in large amounts over a long period. Risk factors for developing CHS include long-term marijuana use, age, gender, and sociocultural background. CHS is rare, but it can be serious and may require medical treatment. The most effective way to manage CHS is to stop using cannabis.
What Causes Cannabinoid Hyperemesis Syndrome? Chronic Marijuana Use
The exact cause of Cannabinoid Hyperemesis Syndrome (CHS) is not fully understood. However, it is believed to be linked to long-term, heavy cannabis use. Marijuana contains over 400 active substances, including THC and CBD, which interact with specific receptors in the brain and digestive tract. Cannabis affects the body’s endocannabinoid system, which helps regulate various functions like mood, appetite, and pain. These substances bind to cannabinoid receptors, influencing the nervous system and gastrointestinal tract, and contributing to both the desired and adverse effects of cannabis. In some people, prolonged exposure to cannabis may disrupt this system, leading to symptoms like nausea and vomiting. Genetic factors and individual differences in how the body processes cannabis may also play a role in the development of CHS. The underlying mechanism of CHS is not fully understood, but potential mechanisms involve complex interactions between cannabinoids, cannabinoid receptors, and the nervous system. Many individuals use cannabis to manage chronic pain, but this long-term use can potentially lead to CHS.
Risk factors for CHS include demographic and behavioral factors such as long-term marijuana use, age, gender, and sociocultural background. These factors may contribute to the likelihood of developing cannabinoid hyperemesis syndrome and cannabis use disorders. The composition of cannabis has changed over the years, with increases in THC and decreases in CBD, which may correlate with increased cases of CHS.
Types of Cannabinoid Hyperemesis Syndrome: Prodromal Phase
Cannabinoid Hyperemesis Syndrome (CHS) does not have distinct “types” but can present in varying severities and patterns. The condition generally follows a progression with three phases:
- Prodromal Phase: This is the early stage where individuals may experience mild symptoms such as nausea, abdominal discomfort, and frequent cannabis use. These symptoms are often mistaken for common digestive issues.
- Hyperemetic Phase: In this phase, severe nausea and vomiting become frequent, and abdominal pain intensifies. People often seek relief by taking hot showers or baths, a key symptom of CHS.
- Recovery Phase: After discontinuing cannabis use, symptoms gradually subside. This phase may take a few days to weeks, depending on the severity of the condition and how long cannabis was used.
Although these phases describe the typical progression, each individual’s experience with CHS may vary. Some may experience recurring episodes if cannabis use continues.
Effects and Risk Factors of Cannabinoid Hyperemesis Syndrome
Cannabinoid Hyperemesis Syndrome (CHS) can have both immediate and long-term effects on health. Untreated CHS can lead to significant health problems, making it important to seek medical attention if symptoms persist. Understanding the risk factors for CHS, such as long-term marijuana use, age, gender, and sociocultural background, can help in identifying individuals who are more likely to experience these effects and risks.
Immediate Effects:
Severe nausea and vomiting: This leads to dehydration and electrolyte imbalances.
Abdominal pain: Intense discomfort often occurs, especially after eating.
Relief from hot showers or baths: This symptom may temporarily ease nausea, leading individuals to seek hot water as a coping mechanism. Frequent hot showers are considered a diagnostic indicator of cannabinoid hyperemesis syndrome, and a significant number of patients report that their symptoms are alleviated by this behavior.
Cannabis hyperemesis syndrome, a subtype of cyclic vomiting syndrome, causes repeated nausea and vomiting, with symptoms resolving during the recovery phase after cannabis cessation.
Long-term Risks:
Dehydration: Prolonged vomiting can cause dehydration, which may require medical treatment. Gastrointestinal issues: Ongoing symptoms may lead to damage to the stomach and intestines. Psychological effects: Chronic symptoms and the impact on daily life can contribute to stress, anxiety, and depression. Recurrence: If cannabis use continues, the condition can reappear and worsen, increasing the risk of long-term health issues.
Long-term risks of CHS are more likely in individuals with certain risk factors, such as chronic marijuana use and specific demographic characteristics. The increasing incidence of CHS in emergency departments highlights the need for awareness and education about the syndrome, as it now affects a broader age range and leads to more related visits and complications.
The most effective way to reduce the effects and risks of CHS is to stop using cannabis. Medical treatment is recommended for managing symptoms and preventing complications.
Cannabinoid Hyperemesis Syndrome Prevalence
Cannabinoid Hyperemesis Syndrome (CHS) is relatively rare, but its prevalence is increasing as cannabis use becomes more widespread. Estimates suggest that CHS affects a small percentage of long-term cannabis users, with studies showing rates ranging from 2% to 10% of frequent cannabis consumers. The condition is more common in individuals who have used cannabis regularly and in large amounts over several years. The prevalence of CHS is influenced by various risk factors, including long-term cannabis use, age, gender, and sociocultural background. However, because CHS is not always diagnosed correctly, its true prevalence may be underreported. With growing awareness, more people are seeking medical help, which may lead to better recognition and reporting of the condition.
CHS syndrome causes cyclic vomiting from chronic cannabis use and is not linked to multiple sclerosis or immune cell-related side effects.
How Is Cannabinoid Hyperemesis Syndrome Diagnosed?
Cannabinoid Hyperemesis Syndrome (CHS) is diagnosed through a combination of medical history, symptom evaluation, and ruling out other conditions. The diagnostic process typically involves:
Medical History: The doctor will ask about cannabis use, including frequency and duration. A history of long-term, heavy cannabis use is a key factor in diagnosing CHS.
Symptom Assessment: The primary symptoms, including severe nausea, vomiting, and abdominal pain, along with the relief from hot showers or baths, help identify CHS.
Exclusion of Other Conditions: Doctors will rule out other potential causes of the symptoms, such as gastrointestinal disorders, infections, or metabolic conditions, through tests and imaging if necessary. A pregnancy test is also essential to rule out potential pregnancies, particularly ectopic pregnancies, among female patients presenting with abdominal pain.
Response to Discontinuing Cannabis: A significant sign of CHS is the resolution of symptoms when cannabis use is stopped. This is a critical diagnostic indicator.
Early morning nausea, repeated vomiting, and disrupted normal eating patterns may indicate cannabis hyperemesis syndrome.
Signs and Symptoms of Cannabinoid Hyperemesis Syndrome: Severe Vomiting
The signs and symptoms of Cannabinoid Hyperemesis Syndrome (CHS) include:
- Severe Nausea: Persistent and intense feelings of nausea, often occurring daily or multiple times a day.
- Frequent Vomiting: Recurrent vomiting that can lead to dehydration and electrolyte imbalances.
- Abdominal Pain: Intense pain in the stomach area, which can range from mild to severe.
- Relief from Hot Showers or Baths: A unique symptom where individuals experience temporary relief from nausea and vomiting by taking hot showers or baths.
- Dehydration: Due to frequent vomiting, dehydration may occur, leading to dry mouth, dizziness, and fatigue.
- Weight Loss: Chronic vomiting and poor appetite can lead to unintentional weight loss.
CHS symptoms, seen in cannabis hyperemesis syndrome, are similar to cyclical vomiting syndrome, causing severe cyclic vomiting episodes, with treatment aimed at symptom relief through supportive care and cannabis cessation.
Complications and Comorbidities of Cannabinoid Hyperemesis Syndrome
Cannabinoid Hyperemesis Syndrome (CHS) can lead to several complications and comorbidities, particularly if left untreated or if cannabis use continues. Understanding the risk factors for CHS can help in identifying individuals who are more likely to experience these complications and comorbidities. These include:
Complications:
- Dehydration: Recurrent vomiting can cause severe dehydration, which may require hospitalization and intravenous fluids.
- Electrolyte Imbalance: Vomiting can lead to an imbalance in electrolytes, increasing the risk of heart problems, muscle weakness, and other health issues.
- Gastrointestinal Damage: Chronic vomiting may result in damage to the stomach lining, leading to gastritis or other digestive problems.
- Nutritional Deficiencies: Ongoing nausea and vomiting can make it difficult to maintain proper nutrition, contributing to weight loss and malnutrition.
A physical exam is important when quitting marijuana, especially if forceful vomiting occurs, as it may indicate CHS syndrome, a condition sometimes linked to cerebral edema. Capsaicin cream is a common treatment, and individuals with bipolar disorder may require additional monitoring.
Comorbidities:
Certain risk factors for CHS, such as long-term cannabis use, can also contribute to the development of comorbidities like mental health issues and substance use disorders.
- Mental Health Issues: The physical symptoms and disruptions to daily life can cause anxiety, stress, and depression.
- Substance Use Disorder: CHS is associated with long-term cannabis use, which may overlap with cannabis dependence or addiction.
- Mood Disorders: Prolonged illness and lifestyle changes may lead to mood disturbances or exacerbate pre-existing mental health conditions.
The best way to manage CHS and prevent complications is to discontinue cannabis use. Early diagnosis and treatment can help mitigate these risks.
Relation to Other Mental Disorders
Cannabinoid Hyperemesis Syndrome (CHS) may be related to other mental disorders, primarily due to its association with long-term cannabis use and the stress it causes in daily life. Certain risk factors for CHS, such as long-term cannabis use, can also increase the likelihood of developing related mental disorders. The key mental health issues linked to CHS include:
- Anxiety: The physical symptoms of CHS, such as frequent vomiting and abdominal pain, can lead to significant anxiety. The unpredictability of symptoms and their impact on daily activities can increase stress levels.
- Depression: Chronic illness, weight loss, and lifestyle disruptions caused by CHS can contribute to feelings of hopelessness, low mood, and depression. Individuals with CHS may feel isolated due to the stigma around cannabis use.
- Substance Use Disorder: CHS occurs in individuals with long-term, heavy cannabis use, which may overlap with cannabis use disorder. Some people with CHS may have difficulty stopping cannabis use, even in the face of negative health effects. Cannabis hyperemesis syndrome characterized as substance abuse due to chronic cannabis use causing severe nausea and vomiting.
- Obsessive-Compulsive Disorder (OCD): The compulsion to take hot showers to relieve symptoms may resemble obsessive behaviors, although this is specific to CHS and not a broader OCD pattern.
While CHS itself is not a mental health disorder, its effects can trigger or worsen pre-existing mental health conditions. Treatment for CHS often requires both physical and psychological support, including counseling to address underlying mental health issues.
How Does Cannabinoid Hyperemesis Syndrome Affect Mental Health?
Cannabinoid Hyperemesis Syndrome (CHS) can indirectly affect mental health. The constant nausea, vomiting, and abdominal pain associated with CHS can lead to stress, anxiety, and depression. Certain risk factors for CHS, such as long-term cannabis use, can also exacerbate mental health issues like anxiety and depression. The symptoms often disrupt daily life, affecting work, relationships, and overall well-being. Additionally, individuals may experience feelings of shame or frustration due to the condition’s link to long-term cannabis use. While CHS itself doesn’t directly impact mental health, the physical symptoms and lifestyle changes caused by the condition can lead to emotional and psychological challenges.
Cannabinoid Hyperemesis Syndrome Prognosis
The prognosis for Cannabinoid Hyperemesis Syndrome (CHS) is generally good if cannabis use is stopped. Once cannabis is discontinued, most people experience relief from symptoms, and the condition typically resolves within a few days to weeks. However, if cannabis use continues, the symptoms may return and worsen over time. In some cases, long-term damage to the gastrointestinal system can occur. Early diagnosis and treatment can help improve recovery outcomes. It’s important to seek medical advice for proper management and avoid further cannabis use to prevent recurring episodes.
Cannabis hyperemesis syndrome (CHS) may require emergency medicine to relieve CHS symptoms, including IV fluids, anti-nausea medications, and supportive care.
Addiction Treatment Options
Treatment for Cannabinoid Hyperemesis Syndrome (CHS) includes:
- Cannabis Cessation: Stopping cannabis use is essential to managing CHS.
- Behavioral Therapy: Cognitive Behavioral Therapy (CBT) helps address cannabis use disorder.
- Medical Treatment: Doctors may provide medications to manage nausea, pain, and dehydration.
- Support Groups: Cannabis Anonymous (CA) offers peer support for recovery.
- Detoxification: Medical detox may be needed for severe symptoms.
- Long-Term Follow-Up: Ongoing care helps prevent relapse and address mental health issues.
These treatments focus on stopping cannabis use and supporting overall recovery.
Cover Cannabinoid Hyperemesis Syndrome Treatment?
Yes, insurance may cover treatment for Cannabinoid Hyperemesis Syndrome (CHS), especially if hospitalization or medical intervention is required after using cannabis, a drug linked to the condition. Coverage typically depends on the plan, but treatments such as hospital visits, IV fluids, anti-nausea medications, and therapy for cannabis use disorder are often included, including care when CHS is more than just a side effect and requires medical evaluation. It’s important to check with the insurance provider to confirm coverage details for specific treatments related to CHS.
Conclusion
Cannabis Hyperemesis Syndrome is a complex condition that can cause serious health complications, including repeated vomiting, cyclical nausea, and gastrointestinal distress. While the symptoms of CHS are often mistakenly attributed to other disorders, early diagnosis and quitting cannabis are crucial for managing the condition. Patients diagnosed with CHS may require emergency medicine or treatments such as anti-nausea medications, topical capsaicin, or hot water hydrotherapy to relieve symptoms. Mental health services administration may also be involved in managing the psychological impact of cannabis use and the challenges of quitting. By increasing awareness and understanding of CHS, healthcare providers can better support patients and reduce the frequency of emergency department visits linked to cannabis-related issues.
Seeking Treatment? We Can Help!
At California Prime Recovery, as an in-network provider we work with most insurance plans, such as:
- Tricare
- Blue Shield
- Magellan Health
- First Health Network
- The Holman Group
- Cigna
- Anthem BCBS
- Aetna
- Humana
- TriWest
- Halcyon
- HMC Healthworks
- Molina
- UnitedHealthcare
- Optum
- UMR
- And More
If you or a loved one are struggling with mental health challenges or substance abuse, reach out to California Prime Recovery today. Our team of compassionate professionals is here to support your journey towards lasting well-being. Give us a call at 866-208-2390.
Also, check out our blogs posted weekly on Medium.
FAQs
What causes Cannabinoid Hyperemesis Syndrome?
CHS is caused by long-term, heavy cannabis use, which affects the body’s endocannabinoid system.
What are the symptoms of CHS?
Symptoms include severe nausea, vomiting, abdominal pain, and relief from hot showers or baths.
How is CHS treated?
The primary treatment is stopping cannabis use. Additional medical care may include anti-nausea medications and IV fluids.
Is CHS dangerous?
If left untreated, CHS can lead to dehydration, electrolyte imbalances, and gastrointestinal damage.
Can CHS be prevented?
CHS can be prevented by avoiding long-term, heavy cannabis use.